Adjuvant therapy of apatinib mesylate tablet for high-risk recurrence of hepatocellular carcinoma after radical Surgical Resection

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2019
This article has no abstract
Epistemonikos ID: d09d9543b778901827e45385c202c01ffb0b8674
First added on: Apr 07, 2025